Participant with damaged facial skin that may interfere with study assessments
Female participant who is pregnant, lactating or planning a pregnancy during the study
Female participant of childbearing potential using combined oral contraceptives approved as acne treatments, in whom the dose has not been stable for at least 6 months prior to the Baseline visit
Participant with known impaired hepatic or renal functions
Participant with active or chronic skin allergies
Clareo Health | AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation
